Rifat Pamukcu
Vermögen: 16 529 $ am 31.05.2026
Vermögen: 16 529 $ am 31.05.2026
Rifat Pamukcu is the founder of Cell Pathways, Inc. Current jobs include Chairman, President & Chief Executive Officer at Midway Pharmaceuticals, Inc. since 2005, President & Chief Executive Officer at Atrin Pharmaceuticals LLC, Chief Executive Officer & Director at RxMP Therapeutics, Inc. since 2016, Director at Virion Therapeutics LLC since 2018, Independent Director at Aprea Therapeutics, Inc. since 2022, Director at Syantra, Inc. since 2019, Director at SIRPant Immunotherapeutics, Inc. since 2021, and Managing Partner at Corami LLC since 2016.
Former job includes Director at Atrin Pharmaceuticals, Inc. Education includes an undergraduate degree from The Johns Hopkins University and a doctorate from the University of Wisconsin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.04.2026 | 18’509 ( 0.15% ) | 16 529 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| APREA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2022 |
Midway Pharmaceuticals, Inc.
Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic therapies | Vorstandsvorsitzender | 01.01.2005 |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Vorstandsvorsitzender | - |
RxMP Therapeutics, Inc.
RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and designs novel hemostatic agents to arrest or prevent excessive bleeding | Vorstandsvorsitzender | 01.01.2016 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Direktor/Vorstandsmitglied | 01.01.2018 |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Direktor/Vorstandsmitglied | 01.01.2021 |
Corami LLC | Corporate Officer/Principal | 01.01.2016 |
Syantra, Inc.
Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides cancer diagnosis services | Direktor/Vorstandsmitglied | 01.01.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Gründer | 01.01.2003 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Midway Pharmaceuticals, Inc.
Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic therapies | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Health Technology |
RxMP Therapeutics, Inc.
RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and designs novel hemostatic agents to arrest or prevent excessive bleeding | Health Technology |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Health Technology |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Syantra, Inc.
Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides cancer diagnosis services | Commercial Services |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Corami LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen